Role of promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene as a risk factor for cerebral venous thrombosis

Stroke

Volumn 39, Issue 2, 2008, Pages 303-307

  Voetsch, Barbara ^a,c,e   Jin, Richard C ^a   Bierl, Charlene ^a   Deus Silva, Leonardo ^c   Camargo, Erica C S ^d,e   Annichino Bizacchi, Joyce M ^c   Handy, Diane E ^a,b   Loscalzo, Joseph ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cerebral venous thrombosis; Genetic risk factors; Glutathione peroxidase; Oxidant stress; Thromboembolic disease

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 3; GPX3 PROTEIN, HUMAN; HORMONE; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION; ADOLESCENT; BLOOD; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; STATISTICAL MODEL; STROKE; VEIN THROMBOSIS;

ADOLESCENT; ADULT; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE PEROXIDASE; HAPLOTYPES; HORMONES; HUMANS; INTRACRANIAL THROMBOSIS; LOGISTIC MODELS; MIDDLE AGED; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); RISK FACTORS; STROKE; VENOUS THROMBOSIS;

EID: 39349104145     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.490094     Document Type: Article

References (27)

1. Bousser MG. Cerebral venous thrombosis: diagnosis and management. J Neurol. 2000;247:252-258.
2. Ludemann P, Nabavi DG, Junker R, Wolff E, Papke K, Buchner H, Assmann G, Ringelstein EB. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke. 1998;29:2507-2510.
3. Martinelli I, Landi G, Merati G, Cella R, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost. 1996;75:393-394.
4. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793-1797.
5. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, Druschky KF, Patscheke H. Prothrombin gene G20210->A transition is a risk factor for cerebral venous thrombosis. Stroke. 1998;29:1765-1769.
6. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood. 2003;102:1363-1366.
7. Cantu C, Alonso E, Jara A, Martinez L, Rios C, Fernandez Mde L, Garcia I, Barinagarrementeria F. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke. 2004;335:1790-1794.
8. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;252:1791-1798.
9. Maddipati KR, Marnett LJ. Characterization of the major hydroperoxidereducing activity of human plasma. Purification and properties of a selenium-dependent glutathione peroxidase. J Biol Chem. 1987;262:17398-17403.
10. Maddipati KR, Gasparski C, Marnett LJ. Characterization of the hydroperoxide-reducing activity of human plasma. Arch Biochem Biophys. 1987;254:9-17.
11. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995;38:87-104.
12. Upchurch GR Jr, Ramdev N, Walsh MT, Loscalzo J. Prothrombotic consequences of the oxidation of fibrinogen and their inhibition by aspirin. J Thromb Thrombolysis. 1998;5:9-14.
13. Vadseth C, Souza JM, Thomson L, Seagraves A, Nagaswami C, Scheiner T, Torbet J, Vilaire G, Bennett JS, Murciano JC, Muzykantov V, Penn MS, Hazen SL, Weisel JW, Ischiropoulos H. Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J Biol Chem. 2004;279:8820-8826.
14. Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest. 1996;97:979-987.
15. Dogru-Abbasoglu S, Kanbagli O, Bulur H, Babalik E, Ozturk S, Aykac-Toker G, Uysal M. Lipid peroxides and antioxidant status in serum of patients with angiographically defined coronary atherosclerosis. Clin Biochem. 1999;32:671-672.
16. Porter M, Pearson DJ, Suarez-Mendez VJ, Blann AD. Plasma, platelet and erythrocyte glutathione peroxidases as risk factors in ischaemic heart disease in man. Clin Sci (Lond). 1992;83:343-345.
17. Muzakova V, Kandar R, Vojtisek P, Skalicky J, Cervinkova Z. Selective antioxidant enzymes during ischemia/reperfusion in myocardial infarction. Physiol Res. 2000;49:315-322.
18. Kenet G, Freedman J, Shenkman B, Regina E, Brok-Simoni F, Holzman F, Vavva F, Brand N, Michelson A, Trolliet M, Loscalzo J, Inbal A. Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke. Arteriosclerosis, thrombosis, and vascular biology. Arterio Thromb Vasc Biol. 1999;19:2017-2023.
19. Bierl C, Voetsch B, Jin RC, Handy DE, Loscalzo J. Determinants of human plasma glutathione peroxidase (GPx-3) expression. J Biol Chem. 2004;279:26839-26845.
20. Voetsch B, Jin RC, Bierl C, Benke KS, Kenet G, Simioni P, Ottaviano F, Damasceno BP, Annichino-Bizzacchi JM, Handy DE, Loscalzo J. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke in young adults and children. Stroke. 2007;38:41-49.
21. Re G, Lanzarini C, Vaona I, Pazzaglia M, Palareti G, Bassein L, Guarnieri C. Systemically circulating oxidative species in human deep venous thrombosis. Eur J Emerg Med. 1998;5:9-12.
22. Voetsch B, Benke KS, Damasceno BP, Siqueira LH, Loscalzo J. Paraoxonase 192 Gln->Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults. Stroke. 2002;33:1459-1464.
23. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995;12:921-927.
24. Martinelli I. Unusual forms of venous thrombosis and thrombophilia. Pathophysiol Haemost Thromb. 2002;32:343-345.
25. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab. 2001;21:2-14.
26. Rieder MJ, Livingston RJ, Daniels MR, Chung M-W, Miyamoto KE, Nguyen CP, Nguyen DA, Poel CL, Robertson PD, Schackwitz WS, Sherwood JK, Witrak LA, Nickerson DA NIEHS-SNPs, Environmental Genome Project, NIEHS ES 15478. 2003; Department of Genome Sciences, Seattle, WA.
27. Arrigo AP. Gene expression and the thiol redox state. Free Radic Biol Med. 1999;27:936-944.